BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37704417)

  • 1. MALT1 Positively Relates to T Helper 1 and T Helper 17 cells, and Serves as a Potential Biomarker for Predicting 30-Day Mortality in Stanford Type A Aortic Dissection Patients.
    Zong J; Yang L; Wei L; Wang D; Wang X; Zhang Z
    Tohoku J Exp Med; 2023 Dec; 261(4):299-307. PubMed ID: 37704417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Th1, Th2, and Th17 cells are dysregulated, but only Th17 cells relate to C-reactive protein, D-dimer, and mortality risk in Stanford type A aortic dissection patients.
    Song M; Deng L; Shen H; Zhang G; Shi H; Zhu E; Xia Q; Han H
    J Clin Lab Anal; 2022 Jun; 36(6):e24469. PubMed ID: 35522124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALT1 positively correlates with Th1 cells, Th17 cells, and their secreted cytokines and also relates to disease risk, severity, and prognosis of acute ischemic stroke.
    Chen X; Zhang X; Lan L; Xu G; Li Y; Huang S
    J Clin Lab Anal; 2021 Sep; 35(9):e23903. PubMed ID: 34273195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MALT1 positively relates to Th17 cells, inflammation/activity degree, and its decrement along with treatment reflects TNF inhibitor response in ankylosing spondylitis patients.
    Yuan J; Xiang L; Wang F; Zhang L; Liu G; Chang X; Zhang A; Tao Y
    J Clin Lab Anal; 2022 Jul; 36(7):e24472. PubMed ID: 35622982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant blood MALT1 and its relevance with multiple organic dysfunctions, T helper cells, inflammation, and mortality risk of sepsis patients.
    Wang Y; Huang Q; He F
    J Clin Lab Anal; 2022 Apr; 36(4):e24331. PubMed ID: 35262976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood MALT1, Th1, and Th17 cells are dysregulated, inter-correlated, and correlated with disease activity in rheumatoid arthritis patients; meanwhile, MALT1 decline during therapy relates to treatment outcome.
    Ye Z; Chen L; Fang Y; Zhao L
    J Clin Lab Anal; 2022 Jan; 36(1):e24112. PubMed ID: 34788483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MALT1 in asthma children: A potential biomarker for monitoring exacerbation risk and Th1/Th2 imbalance-mediated inflammation.
    Liu L; Gao Y; Si Y; Liu B; Liu X; Li G; Wang R
    J Clin Lab Anal; 2022 May; 36(5):e24379. PubMed ID: 35353938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Linkage of Blood MALT1 with CD4+ T Cell Subset, Inflammation, Lipid, and Its Potency as a Biomarker for Predicting Major Adverse Cardiovascular Events in Coronary Heart Disease Patients.
    Zhang L; Li J; Yang Z; Wang S; Liu J; Luan S; Tian G
    Ann Clin Lab Sci; 2023 Jul; 53(4):507-515. PubMed ID: 37625844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MALT1 regulates Th2 and Th17 differentiation
    Wang Q; Wang Y; Liu Q; Chu Y; Mi R; Jiang F; Zhao J; Hu K; Luo R; Feng Y; Lee H; Zhou D; Mi J; Deng R
    Front Immunol; 2022; 13():913830. PubMed ID: 35967391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential role of MALT1 as a candidate biomarker of disease surveillance and treatment response prediction in inflammatory bowel disease patients.
    Wu Z; Bi Y
    J Clin Lab Anal; 2022 Feb; 36(2):e24130. PubMed ID: 34997981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-dependent changes of plasma inflammatory biomarkers in type A aortic dissection patients without optimal medical management.
    Gu J; Hu J; Zhang HW; Xiao ZH; Fang Z; Qian H; Zhong MH; Guo YQ; Zhang EY; Shi YK; Meng W
    J Cardiothorac Surg; 2015 Jan; 10():3. PubMed ID: 25592634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Th1, Th2, Th9, Th17, Th22, and Treg Levels in Aortic Dissection Patients.
    Ye J; Wang Y; Wang Z; Ji Q; Huang Y; Zeng T; Hu H; Ye D; Wan J; Lin Y
    Mediators Inflamm; 2018; 2018():5697149. PubMed ID: 30258282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 in rheumatoid arthritis: Longitudinal change after treatment and correlation with treatment efficacy of tumor necrosis factor inhibitors.
    Wang F; Liu G; Xiang L; Yuan J; Tao Y; Zhang L; Zhang A; Chang X
    J Clin Lab Anal; 2022 Jun; 36(6):e24449. PubMed ID: 35500150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood MALT1 expression could help predict treatment outcomes in psoriasis patients, especially in those receiving biologics.
    Liu Q; Zhang Y; Xu B; Jin X; Yang T; Fan L
    Immun Inflamm Dis; 2024 Apr; 12(4):e1235. PubMed ID: 38578002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosa-associated lymphoid tissue lymphoma translocation protein 1 exaggerates multiple organ injury, inflammation, and immune cell imbalance by activating the NF-κB pathway in sepsis.
    Wang Y; Liu Z; Zhang M; Yu B; Ai F
    Front Microbiol; 2023; 14():1117285. PubMed ID: 36960276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MALT1 serves as a biomarker for estimating disease risk of lupus nephritis: a prospective case-control study.
    Wang M; Huang L; Peng L; Yang Y; Mao J; Zhu N; Wu B
    Ann Transl Med; 2022 Aug; 10(16):874. PubMed ID: 36111027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood MALT1 deficiency is common and relates to unfavorable induction therapy response and survival profile in acute myeloid leukemia patients.
    Geng H; Wang Y; Wang S
    Hematology; 2022 Dec; 27(1):1176-1183. PubMed ID: 36314929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Characteristics, Incidences, and Mortality Rates for Type A and B Aortic Dissections: A Nationwide Danish Population-Based Cohort Study From 1996 to 2016.
    Obel LM; Lindholt JS; Lasota AN; Jensen HK; Benhassen LL; Mørkved AL; Srinanthalogen R; Christiansen M; Bundgaard H; Liisberg M
    Circulation; 2022 Dec; 146(25):1903-1917. PubMed ID: 36321467
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Potential of Targeting Malt1-Dependent TCR Downstream Signaling to Promote the Survival of MHC-Mismatched Allografts.
    Govender L; Mikulic J; Wyss JC; Gaide O; Thome M; Golshayan D
    Front Immunol; 2020; 11():576651. PubMed ID: 33042160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A MALT1 inhibitor suppresses human myeloid DC, effector T-cell and B-cell responses and retains Th1/regulatory T-cell homeostasis.
    Dumont C; Sivars U; Andreasson T; Odqvist L; Mattsson J; DeMicco A; Pardali K; Johansson G; Yrlid L; Cox RJ; Seeliger F; Larsson M; Gehrmann U; Davis AM; Vaarala O
    PLoS One; 2020; 15(9):e0222548. PubMed ID: 32870913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.